Abstract
The leukocyte integrins are essential membrane receptors that mediate leukocyte adhesion to various cells during immune and inflammatory responses including tumor cell killing, leukocyte migration from the bloodstream into inflamed tissues, and phagocytosis of bacteria. The importance of these receptors is underscored in humans with leukocyte adhesion deficiency (LAD), that is caused by the absence or greatly reduced expression of the leukocyte integrins on leukocytes, and which leads to recurrent life-threatening infections and impaired wound healing. These receptors can also exacerbate the diseased state when excessive accumulation of leukocytes occurs at the site of inflammation because of overexpression or increased activation of the leukocyte integrins on these cells. These receptors are involved in a variety of pathological conditions in the vascular system including ischemic reperfusion injury, stroke, and atherosclerosis. The leukocyte integrins augment tissue damage that occurs in autoimmune diseases including rheumatoid arthritis, multiple sclerosis, Crohns disease, and ulcerative colitis. This review will focus on the molecular mechanisms that regulate activation of the leukocyte integrins including transcriptional control of leukocyte gene expression and the role these receptors play in normal and pathological inflammatory processes. Their potential use as markers for disease diagnosis and the prospects for anti-adhesion therapy to ameliorate disease as indicted in a number of animal models will be discussed.
Keywords: leukocyte integrins, inflammation, autoimmune disease, vascular disease
Current Genomics
Title: Expression and Function of the Leukocyte Integrins in Medicine
Volume: 4 Issue: 6
Author(s): John D. Noti
Affiliation:
Keywords: leukocyte integrins, inflammation, autoimmune disease, vascular disease
Abstract: The leukocyte integrins are essential membrane receptors that mediate leukocyte adhesion to various cells during immune and inflammatory responses including tumor cell killing, leukocyte migration from the bloodstream into inflamed tissues, and phagocytosis of bacteria. The importance of these receptors is underscored in humans with leukocyte adhesion deficiency (LAD), that is caused by the absence or greatly reduced expression of the leukocyte integrins on leukocytes, and which leads to recurrent life-threatening infections and impaired wound healing. These receptors can also exacerbate the diseased state when excessive accumulation of leukocytes occurs at the site of inflammation because of overexpression or increased activation of the leukocyte integrins on these cells. These receptors are involved in a variety of pathological conditions in the vascular system including ischemic reperfusion injury, stroke, and atherosclerosis. The leukocyte integrins augment tissue damage that occurs in autoimmune diseases including rheumatoid arthritis, multiple sclerosis, Crohns disease, and ulcerative colitis. This review will focus on the molecular mechanisms that regulate activation of the leukocyte integrins including transcriptional control of leukocyte gene expression and the role these receptors play in normal and pathological inflammatory processes. Their potential use as markers for disease diagnosis and the prospects for anti-adhesion therapy to ameliorate disease as indicted in a number of animal models will be discussed.
Export Options
About this article
Cite this article as:
Noti D. John, Expression and Function of the Leukocyte Integrins in Medicine, Current Genomics 2003; 4 (6) . https://dx.doi.org/10.2174/1389202033490240
DOI https://dx.doi.org/10.2174/1389202033490240 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunosuppressive Drugs in HIV Disease
Current Topics in Medicinal Chemistry Plasminogen Activator Inhibitor-1 in Vascular Thrombosis
Current Drug Targets Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Current Pharmaceutical Design HIF-1α as a Target for Drug Design in Ischemic Injury: Effect of Cobalt Treatment on Mitochondrial DNA Damage in Cells Exposed to H2O2
Letters in Drug Design & Discovery Metabolic Activation of Herbal and Dietary Constituents and Its Clinical and Toxicological Implications: An Update
Current Drug Metabolism The Mast Cell: A Potential Therapeutic Target in Myocardial Infarction
Drug Design Reviews - Online (Discontinued) Editorial: Leptin and the Cardiovascular System - A Target for Therapeutic Interventions
Current Pharmaceutical Design Subject Index Volume 2
Current Pediatric Reviews Drugs Interfering with Apoptosis in Breast Cancer
Current Pharmaceutical Design Cubosomes as Carriers for MRI Contrast Agents
Current Medicinal Chemistry The Biology of p38 Kinase: A Central Role in Inflammation
Current Topics in Medicinal Chemistry Free Radical Scavenger Edaravone Administration Protects against Tissue Plasminogen Activator Induced Oxidative Stress and Blood Brain Barrier Damage
Current Neurovascular Research ECMO for Refractory Hypoxia; Current State of the Art and Future Directions
Current Respiratory Medicine Reviews Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update
Current Cardiology Reviews OPA1 in Cardiovascular Health and Disease
Current Drug Targets Involvement of Hypoxia-Inducible Factors in the Dysregulation of Oxygen Homeostasis in Sepsis
Cardiovascular & Hematological Disorders-Drug Targets Mechanisms of Oxidative Glutamate Toxicity: The Glutamate/Cystine Antiporter System xc¯ as a Neuroprotective Drug Target
CNS & Neurological Disorders - Drug Targets Organ-Level Tissue Engineering Using Bioreactor Systems and Stem Cells: Implications for Transplant Surgery
Current Stem Cell Research & Therapy Pharmacology and Therapeutic Applications of A1 Adenosine Receptor Ligands
Current Topics in Medicinal Chemistry Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice
CNS & Neurological Disorders - Drug Targets